Brief: Agios Reports Business Highlights And Third Quarter 2024 Financial Results
31/10/2024 11:21
Oct 31 (Reuters) - Agios Pharmaceuticals Inc AGIO.O :
* AGIOS REPORTS BUSINESS HIGHLIGHTS AND THIRD QUARTER 2024
FINANCIAL RESULTS
* AGIOS PHARMACEUTICALS INC: QTRLY EPS $16.22
Source text: ID:nGNXks53f
Further company coverage: AGIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Agios Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Agios Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Agios Q2 revenue jumps on US commercial launch of AQVESME
Brief: Agios Pharmaceuticals Q2 Product Revenue USD 44.745 Million Vs. IBES Estimate USD 25.5 Million